Translations:Anti-obesity medication/18/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,162 edits
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 18:16, 7 March 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Anti-obesity medication)
{| class="wikitable"
|+
!Medication Name
!Trade name(s)
!Mechanism of action
!Current FDA Status
!placebo-adjusted percent bodyweight lost (highest dose studied)
|-
|[[Lorcaserin]]
|Belviq
|[[5-HT2C receptor]] agonist
|Withdrawn for safety reasons
| 6.25 percent
|-
|[[Sibutramine]]
|Meridia
|[[Serotonin–norepinephrine reuptake inhibitor]]
|Withdrawn due to cardiovascular risks
| 19.7 percent
|-
|[[Rimonabant]]
|Acomplia, Zimbutli
|[[Cannabinoid receptor antagonist]]
|Withdrawn for safety reasons
| {{convert|2.6 to 6.3|kg}}
|-
|[[Fenfluramine]]
|
|[[Serotonin releasing agent]]
|Withdrawn for safety reasons
| -
|-
|[[Fenfluramine/phentermine]] (fen-phen)
|Pondimin
|
|Withdrawn for safety reasons
|13.9 percent
|-
|[[Dexfenfluramine]]
|Redux
|[[Serotonin releasing agent]]
|Withdrawn for safety reasons
|{{convert|3.5|kg}}
|-
|[[2,4-Dinitrophenol]]
|
|[[Uncoupling agent]]
|Withdrawn for safety reasons
|{{convert|17.1|lb}} per patient on average (uncontrolled study)
Medication Name Trade name(s) Mechanism of action Current FDA Status placebo-adjusted percent bodyweight lost (highest dose studied)
Lorcaserin Belviq 5-HT2C receptor agonist Withdrawn for safety reasons 6.25 percent
Sibutramine Meridia Serotonin–norepinephrine reuptake inhibitor Withdrawn due to cardiovascular risks 19.7 percent
Rimonabant Acomplia, Zimbutli Cannabinoid receptor antagonist Withdrawn for safety reasons 2.6 to 6.3 kilograms (5.7 to 13.9 lb)
Fenfluramine Serotonin releasing agent Withdrawn for safety reasons -
Fenfluramine/phentermine (fen-phen) Pondimin Withdrawn for safety reasons 13.9 percent
Dexfenfluramine Redux Serotonin releasing agent Withdrawn for safety reasons 3.5 kilograms (7.7 lb)
2,4-Dinitrophenol Uncoupling agent Withdrawn for safety reasons 17.1 pounds (7.8 kg) per patient on average (uncontrolled study)
Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Anti-obesity_medication/18/en&oldid=125274"